Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | ABL1 | P00519 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | IDE | P14735 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | RIN1 | Q13671 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | HLCS | P50747 | 6/20 | 0.69 |
| ▸ | CA12 | O43570 | 7/20 | 0.56 |
| ▸ | CA1 | P00915 | 7/20 | 0.56 |
| ▸ | CA2 | P00918 | 7/20 | 0.56 |
| ▸ | CA9 | Q16790 | 7/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biotin SCHEMBL5376391 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL36572 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL9841217 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL410686 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL59420 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL23055065 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL21981206 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL20547409 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL22943835 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL3384633 | 1.00 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747409-A2 | COLLECTION, ASSESSMENT AND EARLY DETECTION OF HUMAN LUNG CANCER BIOMARKERS IN EXHALED BREATH CONDENSATES OF MOUSE ANIMAL MODELS | Hackensack Meridian Health, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260103737-A1 | ENZYMATIC METHODS TO GENERATE HIGH YIELDS OF SEQUENCE SPECIFIC RNA OLIGONUCLEOTIDES WITH EXTREME PRECISION | UNIV MASSACHUSETTS (US) | 2026-04-16 | — | — | US | claimed |
| US-12325873-B2 | Enzymatic methods to generate high yields of sequence specific RNA oligonucleotides with extreme precision | UNIVERSITY OF MASSACHUSETTS (US) | 2025-06-10 | — | — | US | claimed |
| CN-119753176-A | Composition and method for detecting pseudomonas fragicide based on CRISPR/Cas12a | 浙江省海洋水产研究所 | 2025-04-04 | — | — | CN | claimed |
| WO-2025019709-A2 | COLLECTION, ASSESSMENT AND EARLY DETECTION OF HUMAN LUNG CANCER BIOMARKERS IN EXHALED BREATH CONDENSATES OF MOUSE ANIMAL MODELS | HACKENSACK MERIDIAN HEALTH, INC. (US) | 2025-01-23 | — | — | WO | claimed |
| US-20240410022-A1 | COLLECTION, ASSESSMENT AND EARLY DETECTION OF HUMAN LUNG CANCER BIOMARKERS IN EXHALED BREATH CONDENSATES OF MOUSE ANIMAL MODELS | HACKENSACK MERIDIAN HEALTH, INC. (US) | 2024-12-12 | — | — | US | claimed |
| US-20240344056-A1 | IMPROVED METHOD OF SEQUENCING LIBRARY PREPARATION FOR SHORT DNA | SOMAGENICS INC (US) | 2024-10-17 | — | — | US | claimed |
| CN-115029417-B | Slit type Raman enhanced nano-tag, estradiol detection system, kit and application | 首都医科大学 | 2024-09-24 | — | — | CN | claimed |
| US-11999994-B2 | Methods for production and quantification of unique molecular identifier-labeled beads | INTEGRATED DNA TECHNOLOGIES, INC. (US) | 2024-06-04 | — | — | US | claimed |
| EP-4278005-A1 | METHODS FOR PRODUCTION AND QUANTIFICATION OF UNIQUE MOLECULAR IDENTIFIER-LABELED BEADS | Integrated DNA Technologies, Inc. (US) | 2023-11-22 | — | — | EP | claimed |
| CN-115896321-A | CrRNA for rapidly detecting Karenia mikimotoi and primer pair thereof | 闽江学院 | 2023-04-04 | — | — | CN | claimed |
| US-11578348-B2 | Enzymatic methods to generate high yields of sequence specific rna with extreme precision | THE UNIVERSITY OF MASSACHUSETTS (US) | 2023-02-14 | — | — | US | claimed |
| WO-2022256560-A1 | IMPROVED METHOD OF SEQUENCING LIBRARY PREPARATION FOR SHORT DNA | SOMAGENICS, INC. (US) | 2022-12-08 | — | — | WO | claimed |
| EP-3669370-B1 | METHOD FOR DETERMINATION OF CELLULAR MRNA | GOVERNING COUNCIL UNIV TORONTO (CA) | 2022-10-05 | — | — | EP | claimed |
| CN-115029417-A | Gap type Raman enhanced nano-label, estradiol detection system, kit and application | 首都医科大学 | 2022-09-09 | — | — | CN | claimed |
| CN-114774410-A | Primer, kit and detection method for detecting verticillium dahliae based on RPA-CRISPR/Cas12a | 西北农林科技大学 | 2022-07-22 | — | — | CN | claimed |
| WO-2022155282-A1 | METHODS FOR PRODUCTION AND QUANTIFICATION OF UNIQUE MOLECULAR IDENTIFIER-LABELED BEADS | INTEGRATED DNA TECHNOLOGIES, INC. (US) | 2022-07-21 | — | — | WO | claimed |
| US-20220220545-A1 | METHODS FOR PRODUCTION AND QUANTIFICATION OF UNIQUE MOLECULAR IDENTIFIER-LABELED BEADS | INTEGRATED DNA TECHNOLOGIES, INC. | 2022-07-14 | — | — | US | claimed |
| US-11332778-B2 | Methods and systems for nucleic acid amplification | GENAPSYS, INC. (US) | 2022-05-17 | — | — | US | claimed |
| EP-2467142-B1 | 2-(Pyrimidin-5-yl)-thiopyrimidine derivatives as Hsp70 and Hsc70 modulators for the treatment of proliferative disorders | SLOAN KETTERING INST CANCER (US) | 2016-09-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103737-A1 | ENZYMATIC METHODS TO GENERATE HIGH YIELDS OF SEQUENCE SPECIFIC RNA OLIGONUCLEOTIDES WITH EXTREME PRECISION | RNGTT, POLRMT, POLM | TDP1 144/4885MEN1 4880/4885ABL1 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.